Literature DB >> 11438629

Occipital brain perfusion deficits in children with major depressive disorder.

F J Bonte1, M H Trivedi, M D Devous, T S Harris, J K Payne, W A Weinberg, R W Haley.   

Abstract

UNLABELLED: Occipital lobe perfusion defects have been identified on regional cerebral blood flow (rCBF) SPECT scans of adolescent children and young adults with major depressive disorder (MDD). We reinvestigated a series of rCBF SPECT scans obtained several years ago on drug-naive children with a clinical diagnosis of MDD and on healthy children.
METHODS: To test whether visually apparent abnormalities in rCBF constitute statistically significant differences between patients, given the relatively small sample sizes, we applied the technique of statistical parametric mapping (SPM).
RESULTS: Two groups of patients were identified: 8 with significant posterior flow deficits in the occipital cortex (Brodmann's areas 18 and 19), usually symmetric, and best visualized on paramedian sagittal sections, and 13 without obvious occipital perfusion deficits but with anterior rCBF deficits in a pattern often described in the literature, attaining statistical significance in the right frontal region. Other localizations in the left frontal and bilateral prefrontal regions did not attain significance, but each localization contained statistically significant maxima (z scores). The scan findings of all 18 healthy children were normal.
CONCLUSION: With the aid of SPM, 2 groups of children with significantly different rCBF behavior were identified. The reason for this difference is not known but should be investigated to determine its possible significance to patients with MDD.

Entities:  

Mesh:

Year:  2001        PMID: 11438629

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Regional cerebral perfusion abnormalities in developmental language disorder. Statistical parametric mapping analysis.

Authors:  Jun Won Hwang; Jeong-Bum Lee; Boong-Nyun Kim; Ho-Young Lee; Dong-Soo Lee; Min-Sup Shin; Soo-Churl Cho
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04-20       Impact factor: 5.270

2.  Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.

Authors:  Jodie P Gray; Veronika I Müller; Simon B Eickhoff; Peter T Fox
Journal:  Am J Psychiatry       Date:  2020-02-26       Impact factor: 18.112

3.  A meta-analytic study of changes in brain activation in depression.

Authors:  Paul B Fitzgerald; Angela R Laird; Jerome Maller; Zafiris J Daskalakis
Journal:  Hum Brain Mapp       Date:  2008-06       Impact factor: 5.038

4.  Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans.

Authors:  Feng Liu; Wenbin Guo; Dengmiao Yu; Qing Gao; Keming Gao; Zhimin Xue; Handan Du; Jianwei Zhang; Changlian Tan; Zhening Liu; Jingping Zhao; Huafu Chen
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

5.  Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder.

Authors:  Rubai Zhou; Fan Wang; Guoqing Zhao; Weiping Xia; Daihui Peng; Ruizhi Mao; Jingjing Xu; Zuowei Wang; Wu Hong; Chen Zhang; Yong Wang; Yousong Su; Jia Huang; Tao Yang; Jijun Wang; Jun Chen; Lena Palaniyappan; Yiru Fang
Journal:  Transl Psychiatry       Date:  2018-10-11       Impact factor: 6.222

6.  Cortical and subcortical gray matter alterations in first-episode drug-naïve adolescents with major depressive disorder.

Authors:  Ji Hyun Kim; Sang-Il Suh; Ho-Jun Lee; Jong-Ha Lee; Moon-Soo Lee
Journal:  Neuroreport       Date:  2019-12-10       Impact factor: 1.837

7.  Differentiating Melancholic and Non-melancholic Major Depressive Disorder Using Fractional Amplitude of Low-Frequency Fluctuations.

Authors:  Yingying Zhang; Xilong Cui; Yangpan Ou; Feng Liu; Huabing Li; Jindong Chen; Jingping Zhao; Guangrong Xie; Wenbin Guo
Journal:  Front Psychiatry       Date:  2022-02-02       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.